SEC Filings

Form S-3
IOVANCE BIOTHERAPEUTICS, INC. filed this Form S-3 on 09/07/2018
Document Outline
Entire Document (967 KB)
Subdocument 1 - S-3 - FORM S-3
Page 1 - As filed with the Securities and Exchange Commission on September 7, 2018
Page 2 - Approximate date of commencement of proposed sale to the public: From time to time after the effecti
Page 3 - N/A
Page 4 - The information in this prospectus is not complete and may be changed. We may not sell these securit
Page 5 - PROSPECTUS
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - Series A Convertible Preferred Stock
Page 15 - Series B Convertible Preferred Stock
Page 16 - N/A
Page 17 - General
Page 18 - Conversion and Exchange
Page 19 - Remedies if an Event of Default Occurs
Page 20 - Merger or Consolidation
Page 21 - Changes Not Requiring Approval
Page 22 - Covenant Defeasance
Page 23 - Resignation of Trustee
Page 24 - N/A
Page 25 - General
Page 26 - Exercise of Rights
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - PROSPECTUS
Page 32 - PART II
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Subdocument 2 - EX-4.1 - EXHIBIT 4.1
Page 1 - Exhibit 4.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - [Signature Page to Base Indenture]
Page 52 - [Signature Page to Base Indenture]
Page 53 - N/A
Subdocument 3 - EX-5.1 - EXHIBIT 5.1
Page 1 - EXHIBIT 5.1
Page 2 - Corporate Action ), and will not conflict with or constitute a breach of the terms of any agreement
Page 3 - Rights Agreement ) to be entered into by the Company and a rights agent (each, a Rights Agent ) and
Page 4 - N/A
Subdocument 4 - EX-12.1 - EXHIBIT 12.1
Page 1 - N/A
Subdocument 5 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A
Subdocument 6 - EX-23.2 - EXHIBIT 23.2
Page 1 - N/A